Biblio

20 resultats trouvés
Filtres: Auteur is Thevenot, T.  [Clear All Filters]
A
Moreau R., Elkrief L., Bureau C., Perarnau J.-M, Thevenot T., Saliba F., Louvet A., Nahon P., Oberti F., Anty R. et al..  2017.  A randomized trial of 6-month norfloxacin therapy in patients with Child-Pugh class C cirrhosis. JOURNAL OF HEPATOLOGY. 66:S1.
Garioud A., Cadranel J.-F, Nousbaum J.-B, Smail A., Lison H., Thevenot T., Medmoun M., Belloula D., Kazerouni F., Hadj-Nacer K. et al..  2015.  ABDOMINAL ULTRASONOGRAPHY GUIDANCE REDUCES THE RISK OF COMPLICATIONS AND IMPROVES SUCCESS RATE AFTER LIVER BIOPSY: RESULTS OF A META-ANALYSIS COMPARING THE USE OF ULTRASOUND GUIDANCE TO THE ``BLIND METHOD''. JOURNAL OF HEPATOLOGY. 62:S825.
Thevenot T., Bureau C., Oberti F., Anty R., Louvet A., Plessier A., Rudler M., Heurgue-Berlot A., Rosa I., Talbodec N. et al..  2014.  ALBUMIN INFUSION FOR BACTERIAL INFECTIONS OTHER THAN SPONTANEOUS BACTERIAL PERITONITIS IN CIRRHOTIC PATIENTS: A MULTICENTER RANDOMIZED CONTROLLED STUDY (ALB-CIRINF STUDY). JOURNAL OF HEPATOLOGY. 60:S29.
Di Martino V., Richou C., Cervoni J.-P, Weil D., Vanlemmens C., Thevenot T..  2015.  ARE EXTENDED DURATIONS AND/OR RIBAVIRIN USEFUL FOR GENOTYPE 1 (G1) CIRRHOTIC PATIENTS WHO RECEIVE DAAS COMBINATION? A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (RCTS) JOURNAL OF HEPATOLOGY. 62:S644-S645.
B
Cadranel J.-FD, Allaire M., Blasco-Perrin H., Thevenot T., Chagneau-Derrode C., Pariente E.-A, Garioud A., Lison H., Causse X., Adhoute X. et al..  2014.  BACTERIAL ENDOCARDITIS IN PATIENTS WITH CIRRHOSIS: A MULTICENTER RETROSPECTIVE STUDY OF 78 CASES. JOURNAL OF HEPATOLOGY. 60:S220-S221.
C
Kerbert A.J, Weil D., Verspaget H.W, Moreno J.-P, van Hoek B., Di Martino V., Coenraad M.J, Thevenot T..  2015.  COPEPTIN IS AN INDEPENDENT PROGNOSTIC FACTOR IN LIVER CIRRHOSIS. JOURNAL OF HEPATOLOGY. 62:S369.
E
Weil D., Di Martino V., Levesque E., McPhail M., Cavallazzi R., Theocharidou E., Cholongitas E., Galbois A., Pan H.-C, Karvellas C. et al..  2015.  EXTERNAL VALIDATION OF THE CLIF-SOFA IN CIRRHOTIC PATIENTS ADMITTED TO INTENSIVE CARE UNITS (ICUS): A META-ANALYSIS. JOURNAL OF HEPATOLOGY. 62:S350-S351.
H
Garioud A., Cadranel J-F., Pauwels A., Thevenot T., Louvet A., Dao T., Sogni P., Talbodec N., Bureau C., Thabut D. et al..  2015.  HUMAN ALBUMIN USE IN CIRRHOTIC PATIENTS IN FRANCE: RESULTS OF THE NATIONAL ``ALBU-LIVE'' SURVEY. JOURNAL OF HEPATOLOGY. 62:S833.
I
Barrault C., Cadranel J.-F, Locher C., Thevenot T., Skinasi F., Labarriere D., Valerie B., Le Bricquir Y., Quentin V., Garioud A. et al..  2018.  Impact of baclofen treatment in 212 alcohol-dependant patients of the french ``OBADE-ANGH'' series. JOURNAL OF HEPATOLOGY. 68:S42.
Faivre M, Cottet V, Bour J-B, Richou C, Valmary-Degano S, Thiefin G, Andreoletti L, Geist C, Schvoerer E, Malve B et al..  2019.  Impact of Cytomegalovirus Infection on the Outcome of Patients With Cirrhosis A Preliminary Study. JOURNAL OF CLINICAL GASTROENTEROLOGY. 53:236-241.
L
Weil D., Christmann P.-Y, Sailley N., Thevenot T..  2018.  Letter: innovative use of the alfapump system to treat a small hepatocellular carcinoma. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 47:695-696.
Thevenot T., Study SComm ProPI.  2018.  Letter: using a placebo as a comparator to rifaximin for the primary prophylaxis of spontaneous bacterial peritonitis-is there really an ethical concern? ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 47:1047-1048.
Cadranel J.-F, Ollivier-Hourmand I., Bureau C., Zerkly S., Thevenot T., Cacoub P., Macaigne G., Alric L., Garioud A., Jouannaud V. et al..  2015.  LIVER CIRRHOSIS IS INDEPENDENTLY ASSOCIATED WITH MORTALITY IN PATIENTS WITH BACTERIAL ENDOCARDITIS: RESULTS OF A CASE CONTROL MULTICENTER STUDY OF 202 CASES. JOURNAL OF HEPATOLOGY. 62:S358.
M
Weil D., Cervoni J.P, Fares N., Rudler M., Bureau C., Plessier A., Dao T., Pauwels A., Thabut D., Castellani P. et al..  2015.  MANAGEMENT OF GASTRIC VARICES: A FRENCH NATIONAL SURVEY. JOURNAL OF HEPATOLOGY. 62:S382-S383.
Paugam-Burtz C., Levesque E., Louvet A., Thabut D., Amathieu R., Bureau C., Camus C., Chanques G., Faure S., Ferrandiere M. et al..  2020.  Management of liver failure in general intensive care unit. ANAESTHESIA CRITICAL CARE & PAIN MEDICINE. 39:143-161.
N
Grillet F., Calame P., Cervoni J.-P, Weil D., Thevenot T., Ronot M., Delabrousse E..  2021.  Non-invasive diagnosis of severe alcoholic hepatitis: Usefulness of cross-sectional imaging. DIAGNOSTIC AND INTERVENTIONAL IMAGING. 102:247-254.
P
Di Martino V., Coutris C., Cervoni J.-P, Dritsas S., Weil D., Thevenot T..  2014.  PROGNOSTIC VALUE OF C-REACTIVE PROTEIN LEVELS IN PATIENTS WITH CIRRHOSIS. JOURNAL OF HEPATOLOGY. 60:S218.
S
Verhoeven F., Weil-Verhoeven D., Thevenot T., Prati C., Di Martino V., Wendling D..  2018.  SAFETY OF TNF BLOCKERS IN CASE OF NON-ALCOHOLIC FATTY LIVER DISEASE AND CIRRHOSISA SYSTEMATIC REVIEW. ANNALS OF THE RHEUMATIC DISEASES. 77:1381-1382.
Weil D., Di Martino V., Levesque E., McPhail M., Cavallazzi R., Theocharidou E., Cholongitas E., Galbois A., Pan H.-C, Karvellas C. et al..  2015.  SIX-MONTH MORTALITY OF CIRRHOTIC PATIENTS WHO SURVIVED INTENSIVE CARE: A META-ANALYSIS. JOURNAL OF HEPATOLOGY. 62:S357.
T
Cervoni J.-P, Weil D., Bureau C., Oberti F., Anty R., Louvet A., Plessier A., Rudler M., Heurgue-Berlot A., Rosa I. et al..  2017.  The Quick SOFA, a simple bedside score, identifies hospitalized cirrhotic patients with poor outcomes. JOURNAL OF HEPATOLOGY. 66:S379-S380.